Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.87
0.385.07%
Last update: Oct 21, 4:00 PM
$7.87
0.385.07%
Oculis Holding AG (OCS) Stock Price, Quote, News & History
OCSNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED);...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Oculis Holding (NASDAQ:OCS) through any online brokerage.
Other companies in Oculis Holding’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Oculis Holding has a consensus price target of $38.40.
The stock price for Oculis Holding (NASDAQ: OCS) is $7.87 last updated October 21, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Oculis Holding.
Oculis Holding does not have any upcoming earnings scheduled.
There is no upcoming split for Oculis Holding.
Oculis Holding is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
